PULSION Medical Systems SE Reports Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013; Provides Earnings Guidance for the Year 2013
For the nine months, the company reported sales of 27.049 million compared to 25.439 million, operating profit of 7.228 million compared to 6.933 million, profit before interest and taxes (EBIT) of 7.006 million compared to 6.998 million, profit before taxes (EBT) of 6.987 million compared to 7.038 million and profit attributable to shareholders of the group parent company of 6.370 million or 0.77 per diluted share compared to 5.127 million or 0.59 per diluted share for the last year. Cash flow from operating activities after changes in net working capital was 2,759,000 compared to 6,442,000 and purchase of intangible assets was 939,000 compared to 63,000 for the last year.
For the full financial year 2013 the company is targeting growth of at least 6%. The company expects EBITDA for the full year to land within a corridor of between 12.5 and 13.0 million. The company continue to predict an EBIT margin for the full year within a target corridor of between 24 % and 28 %. Prediction of earnings per share (EPS) within a range of 0.95 to 1.05, approximately 20 % higher than the previous year's figure of 0.82, remains unchanged.